4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Trial details
- Registry ID
- NCT06864988
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationNCT06864988 | 4D Molecular Therapeutics | Phase 3 | Active not recruiting | 2027-06Estimated |
| Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationNCT07064759 | 4D Molecular Therapeutics | Phase 3 | Recruiting | 2027-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |